References
- World Health Organization (WHO)Guideline on Submission of Documentation for Prequalification of Multisource (Generic) Finished Pharmaceutical Products (FPPs) Approved by Stringent Regulatory Authorities (SRAs) Document number: PQP09001/Ver.1GenevaWHO2011 Available from: http://apps.who.int/prequal/info_applicants/Guidelines/PQProcGenericSRA_July2011.pdfAccessed April 26, 2012
- International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). FAQs: ICH organizational structure [web page on the Internet]GenevaICH2012 Available from: http://www.ich.org/about/faqs.htmlAccessed April 26, 2012
- BateRHessKMooneyLAntimalarial medicine diversion: stock-outs and other public health problemsRes Rep Trop Med201011924
- RatanawijitrasinSWondemagegnehuEEffective Drug Regulation: A Multicountry StudyGenevaWHO2002 Available from: http://apps.who.int/medicinedocs/en/d/Js2300e/Accessed April 18, 2012
- HillSJohnsonKEmerging Challenges and Opportunities in Drug Registration and Regulation in Developing CountriesLondonDFID Health Systems Resource Centre2004 Available from: http://www.hlsp.org/LinkClick.aspx?fileticket=0TXMdaAk5KA%3D&tabid=1643Accessed April 18, 2012
- WHOPrequalification of medicines by WHO [web page on the Internet]. Factsheet No. 278GenevaWHO2010 Available from: http://www.who.int/mediacentre/factsheets/fs278/en/index.htmlAccessed April 18, 2012
- BateRMooneyLHessKMedicine registration and medicine quality: a preliminary analysis of key cities in emerging marketsRes Rep Trop Med201018993
- BateRCoticelliPTrenRAttaranAAntimalarial drug quality in the most severely malarious parts of Africa – a six country studyPLoS ONE200835e213218461128
- BateRHessKAnti-malarial drug quality in Lagos and Accra – a comparison of various quality assessmentsMalar J2010915710.1186/1475-2875-9-15720537190
- BateRTrenRMooneyLPilot study of essential drug quality in two major cities in IndiaPLoS ONE200946e600319547757
- OnwujekweOKaurHDikeNQuality of anti-malarial drugs provided by public and private healthcare providers in south-east NigeriaMalar J200982219208221
- AtemnkengMADe CockKPlaizier-VercammenJQuality control of active ingredients in artemisinin-derivative antimalarials within Kenya and DR CongoTrop Med Int Health2007121687417207150
- BateRJinGZMathurADoes price reveal poor-quality drugs? Evidence from 17 countriesJ Health Econ20113061150116321917346
- www.gpo.gov [homepage on the Internet]Drugs and devices. Part A: Drugs and Devices Sec. 360n - Priority review to encourage treatments for tropical diseasesFood and drugs Federal food, drug and cosmetic Act 21 USC. United States Code2010 EditionU.S. Government Printing Office2010 Available from: http://www.gpo.gov/fdsys/pkg/USCODE-2010-title21/html/USCODE-2010-title21-chap9-subchapV-partA-sec360n.htmAccessed July 3, 2012
- United States Agency for International Development (USAID)Growing threat of substandard and counterfeit medicines in developing countries addressed by new USAID-USP cooperative agreement [press release]Washington DCUSAID20091026 Available from: http://www.usaid.gov/content/growing-threat-substandard-and-counterfeit-medicines-developing-countries-addressed-newAccessed June 14, 2012